Preparation and drug release behaviors of nimodipine-loaded poly(caprolactone)-poly(ethylene oxide)-polylactide amphiphilic copolymer nanoparticles

被引:247
作者
Hu, Y
Jiang, XQ
Ding, Y
Zhang, LY
Yang, CZ [1 ]
Zhang, JF
Chen, JN
Yang, YH
机构
[1] Nanjing Univ, Dept Polymer Sci & Engn, Lab Mesoscop Mat Sci, Nanjing 210093, Peoples R China
[2] Nanjing Univ, Dept Phys, Nanjing 210093, Peoples R China
[3] Nanjing Univ, Jiangsu Provincial Lab Nano Technol, Nanjing 210093, Peoples R China
[4] Nanjing Univ, State Kev Lab Pharmaceut Biotechnol, Nanjing 210093, Peoples R China
关键词
nimodipine; epsilon-caprolactone; poly(ethylene glycol); L-lactide; nanoparticles;
D O I
10.1016/S0142-9612(03)00021-8
中图分类号
R318 [生物医学工程];
学科分类号
0831 ;
摘要
Amphiphilic block copolymers, poly(caprolactone)-poly(ethylene glycol)-poly(lactide) (PCELA), were synthesized by ring opening polymerization of caprolactone and lactide initiated with the hydroxyl groups of poly(ethylene glycol) (PEG). These copolymers could form micelle-like nanoparticles due to their amphiphilic characteristic. From the observation of transmission electron microscopy (TEM), the nanoparticles exhibited a regular spherical shape with core-shell structure. The critical micelle concentrations (CMC) of these nanoparticles in water were decreased as molecular weight of PEG decreased. The particle sizes obtained by dynamic light scattering of these nanoparticles were in the range of 100-200 nm, and increased as the hydrophobic property of the nanoparticles increased. Nimodipine as a model drug was loaded in these nanoparticles to investigate the drug release behavior. It was found that the chemical composition of the nanoparticles was a key factor in controlling nanoparticle size, nanoparticle yields, drug-entrapment efficiency, and drug release behavior. When the PEG content is about 2% (wt), the release profile of PCELA nanoparticles appeared to follow zero-order kinetics. (C) 2003 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:2395 / 2404
页数:10
相关论文
共 26 条
[1]  
DAIRUI C, 2000, POLYM INT, V49, P269
[2]   THE PY SCALE OF SOLVENT POLARITIES [J].
DONG, DC ;
WINNIK, MA .
CANADIAN JOURNAL OF CHEMISTRY-REVUE CANADIENNE DE CHIMIE, 1984, 62 (11) :2560-2565
[3]   Defining the drug incorporation properties of PLA-PEG nanoparticles [J].
Govender, T ;
Riley, T ;
Ehtezazi, T ;
Garnett, MC ;
Stolnik, S ;
Illum, L ;
Davis, SS .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2000, 199 (01) :95-110
[4]   BIODEGRADABLE LONG-CIRCULATING POLYMERIC NANOSPHERES [J].
GREF, R ;
MINAMITAKE, Y ;
PERACCHIA, MT ;
TRUBETSKOY, V ;
TORCHILIN, V ;
LANGER, R .
SCIENCE, 1994, 263 (5153) :1600-1603
[5]   PHARMACOKINETICS AND DISTRIBUTION OF A BIODEGRADABLE DRUG-CARRIER [J].
GRISLAIN, L ;
COUVREUR, P ;
LENAERTS, V ;
ROLAND, M ;
DEPREZDECAMPENEERE, D ;
SPEISER, P .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1983, 15 (03) :335-345
[6]  
HAIXIONG G, 2002, J PHARM SCI, V91, P1463
[7]  
HAIXIONG G, 2000, J APPL POLYM SCI, V75, P874
[8]   OXIDATION OF POLYETHYLENE GLYCOLS BY ALCOHOL-DEHYDROGENASE [J].
HEROLD, DA ;
KEIL, K ;
BRUNS, DE .
BIOCHEMICAL PHARMACOLOGY, 1989, 38 (01) :73-76
[9]   INFLUENCE OF CARDIOPULMONARY RESUSCITATION ON PLASMA-CONCENTRATIONS OF NIMODIPINE IN THE DOG [J].
HUYGHENS, LP ;
ROSSEEL, MT ;
CALLE, PA ;
BUYLAERT, WA .
JOURNAL OF PHARMACY AND PHARMACOLOGY, 1987, 39 (12) :991-996
[10]   Clonazepam release from core-shell type nanoparticles in vitro [J].
Jeong, YI ;
Cheon, JB ;
Kim, SH ;
Nah, JW ;
Lee, YM ;
Sung, YK ;
Akaike, T ;
Cho, CS .
JOURNAL OF CONTROLLED RELEASE, 1998, 51 (2-3) :169-178